Pharmacodynamic Effects of Atorvastatin vs. Rosuvastatin on pLatelet Reactivity in Stable Patients With Coronary Artery Disease Treated With Dual Antiplatelet Therapy
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Atorvastatin (Primary) ; Rosuvastatin (Primary) ; Clopidogrel; Salicylic acid
- Indications Coronary artery disease; Embolism and thrombosis
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms PEARL
- 03 May 2013 Planned End Date changed from 1 Jun 2014 to 1 Jun 2015 as reported by ClinicalTrials.gov.
- 11 Apr 2012 New trial record